Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Cash from Financing Activities (2016 - 2025)

Innospec's Cash from Financing Activities history spans 16 years, with the latest figure at -$20.6 million for Q4 2025.

  • For Q4 2025, Cash from Financing Activities fell 15.73% year-over-year to -$20.6 million; the TTM value through Dec 2025 reached -$63.9 million, down 81.02%, while the annual FY2025 figure was -$63.9 million, 81.02% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was -$20.6 million at Innospec, down from -$10.8 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $900000.0 in Q1 2022 and bottomed at -$28.7 million in Q2 2025.
  • The 5-year median for Cash from Financing Activities is -$8.8 million (2021), against an average of -$9.6 million.
  • The largest annual shift saw Cash from Financing Activities skyrocketed 400.0% in 2022 before it crashed 1300.0% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at -$6.8 million in 2021, then plummeted by 150.0% to -$17.0 million in 2022, then decreased by 20.0% to -$20.4 million in 2023, then grew by 12.75% to -$17.8 million in 2024, then decreased by 15.73% to -$20.6 million in 2025.
  • Per Business Quant, the three most recent readings for IOSP's Cash from Financing Activities are -$20.6 million (Q4 2025), -$10.8 million (Q3 2025), and -$28.7 million (Q2 2025).